search
Back to results

Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System

Primary Purpose

Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement

Status
Completed
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
Incision technique
Incision technique
Sponsored by
Zimmer Biomet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The patients who need artificial knee joint replacement in ordinary medical consultation are selected as the subjects.

Exclusion Criteria:

  • Patients with infections such as osteomyelitis, or sepsis (Because the affected part is lesioned, excellent surgical results cannot be obtained.)

Sites / Locations

  • National Hospital Organization, Osaka National Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Tri-Vector Approach

Mini Mid-Vastus Approach

Arm Description

Outcomes

Primary Outcome Measures

Force from femoral and tibial side to retract and bring visual field into view

Secondary Outcome Measures

Incision length
Visual determination of the extension and flexion gap

Full Information

First Posted
November 9, 2009
Last Updated
March 25, 2019
Sponsor
Zimmer Biomet
Collaborators
Biomet Japan, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01010828
Brief Title
Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System
Official Title
Efficacy and Safety of Vanguard PS Knee Joint System Using MIS Technique
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
October 1, 2009 (Actual)
Primary Completion Date
March 31, 2012 (Actual)
Study Completion Date
March 31, 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zimmer Biomet
Collaborators
Biomet Japan, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will show whether Tri-Vector method can ensure more extensive visual field and conduct the precise surgery when compared with Mini Mid-Vastus method by conducting 2 types of skin incision approach, Tri-Vector for 36 patients or Mini-Mid Vastus for 36 patients in Vanguard PS artificial knee joint total replacement observational period before and during surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
72 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tri-Vector Approach
Arm Type
Active Comparator
Arm Title
Mini Mid-Vastus Approach
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Incision technique
Intervention Description
Tri-Vector Approach retains the majority of 3 vectors of quadriceps.
Intervention Type
Procedure
Intervention Name(s)
Incision technique
Intervention Description
Mini Mid-Vastus Approach
Primary Outcome Measure Information:
Title
Force from femoral and tibial side to retract and bring visual field into view
Time Frame
intraoperatively
Secondary Outcome Measure Information:
Title
Incision length
Time Frame
intraoperatively
Title
Visual determination of the extension and flexion gap
Time Frame
intraoperatively

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The patients who need artificial knee joint replacement in ordinary medical consultation are selected as the subjects. Exclusion Criteria: Patients with infections such as osteomyelitis, or sepsis (Because the affected part is lesioned, excellent surgical results cannot be obtained.)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Takashi Miyamoto, MD
Organizational Affiliation
Osaka Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Hospital Organization, Osaka National Hospital
City
Osaka
ZIP/Postal Code
540-0006
Country
Japan

12. IPD Sharing Statement

Learn more about this trial

Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System

We'll reach out to this number within 24 hrs